Natco Pharma Ltd.
Snapshot View

573.40 -0.85 ▼-0.2%

08 December 2022, 04:01:00 PM
Volume: 3,402

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.natcopharma.co.in
Market Cap 10,473.30 Cr.
Enterprise Value(EV) 10,117.43 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 22.30 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 25.71 Trailing Twelve Months Ending 2022-09
Industry PE 34.64 Trailing Twelve Months Ending 2022-09
Book Value / Share 250.40 Trailing Twelve Months Ending 2022-09
Price to Book Value 2.29 Calculated using Price: 573.40
Dividend Yield 0.78 Period Ending 2022-03
No. of Shares Subscribed 18.26 Cr. 182,557,165 Shares
FaceValue 2
Company Profile
Natco Pharma is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). It is also engaged in contract manufacturing business, whereby it undertake selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products. It has diversified into the business of crop health sciences to leverage is skills in organic chemistry.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.15%
1 Week
-0.67%
1 Month
-7.69%
3 Month
-5.53%
6 Month
-16.71%
1 Year
-31.28%
2 Year
-40.92%
5 Year
-38.40%
10 Year
+535.98%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 15.58 16.57 14.62 33.21 29.70 19.75 12.71 11.27 4.06
Return on Capital Employed (%) 18.02 15.62 18.04 39.21 35.28 23.71 14.82 13.99 4.86
Return on Assets (%) 8.62 10.10 9.72 23.43 23.05 16.02 10.30 9.43 3.43

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 726 846 1,296 1,649 3,072 3,489 3,774 4,122 4,264 4,571
Non Curr. Liab. 151 119 28 38 47 83 118 143 135 106
Curr. Liab. 312 414 493 627 592 729 685 526 710 401
Minority Int. 7 5 5 4 4 2 11 2
Equity & Liab. 1,196 1,384 1,822 2,318 3,715 4,303 4,588 4,792 5,109 5,078
Non Curr. Assets 828 901 985 1,230 1,584 1,956 2,262 2,447 2,612 2,675
Curr. Assets 368 483 837 1,087 2,131 2,347 2,326 2,345 2,497 2,403
Misc. Exp. not W/O
Total Assets 1,196 1,384 1,822 2,318 3,715 4,303 4,588 4,792 5,109 5,078

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 739 825 1,141 2,020 2,185 2,095 1,915 2,052 1,945 2,474
Other Income 17 15 10 14 40 130 107 106 99 99
Total Income 756 840 1,151 2,034 2,225 2,225 2,022 2,158 2,044 2,573
Total Expenditure -560 -612 -869 -1,337 -1,256 -1,300 -1,332 -1,448 -1,681 -1,900
PBIDT 196 228 283 697 969 925 690 710 363 673
Interest -37 -32 -23 -19 -15 -19 -22 -13 -18 -20
Depreciation -30 -47 -51 -54 -66 -81 -100 -117 -143 -155
Taxation -31 -4 -53 -140 -192 -182 -111 -137 -32 -90
Exceptional Items -15
PAT 98 130 156 485 695 642 458 442 170 407
Minority Interest 5 4 1 1 1 2 3 -2
Share Associate
Other Related Items
Consolidated Net Profit 103 135 157 486 696 644 461 441 170 407
Adjusted EPS 6 8 9 28 38 35 25 24 9 22

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 61 144 93 112 346 464 669 417 299 47
Cash Fr. Inv. -107 -109 -115 -176 -299 -1,116 -612 -167 -103 -5
Cash Fr. Finan. 26 -35 29 154 -48 651 -51 -251 -186 35
Net Change -20 0 7 91 -1 -1 6 -1 10 76
Cash & Cash Eqvt 10 10 12 -74 24 22 28 20 26 111

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 48.91 48.91 48.87 48.87 48.87 48.86 48.81 48.80 48.80
Public 51.09 51.09 51.13 51.13 51.13 51.14 51.19 51.20 51.20
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 05 Dec 2022
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for V C Nannapaneni
Mon, 05 Dec 2022
Announcement under Regulation 30 (LODR)-Press Release / Media Release
NATCO RECEIVES FAVOURABLE JUDGEMENT FMC APPEAL DISMISSED
Sat, 03 Dec 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
issue of duplicate share certificates

Technical Scans View Details >>

Thu, 08 Dec 2022
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 1 Month High Decrease 1 Month
High Decrease 1 Year High Decrease 1 Year
Closing Near 20 SMA Closing Near 20 SMA
CCI Trending Down CCI Trending Down

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,362.76 980.95 -3.6%
Cipla Ltd. 89,585.15 1,110.00 +0.4%
Divi's Laboratories Ltd. 87,333.85 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. 72,223.59 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. 67,735.51 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. 54,831.55 1,620.10 -0.4%
Abbott India Ltd. 43,044.71 20,257.00 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 57.34 980.95 -3.6%
Cipla Ltd. Consolidated 2022-09 34.91 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-09 29.18 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.23 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 80.68 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 68.80 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-09 48.82 20,257.00 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.43 980.95 -3.6%
Cipla Ltd. Consolidated 2022-09 4.09 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-09 7.20 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.48 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.32 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.00 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-09 15.86 20,257.00 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 0.00 20,257.00 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 29.95 20,257.00 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 29.95 20,257.00 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,257.00 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 798.70 20,257.00 +0.2%

FAQ's On Natco Pharma Ltd.

What is Natco Pharma share price?

Can I buy Natco Pharma shares now?

What is the Dividend Yield of Natco Pharma?

What is the Market Cap of Natco Pharma?

What are the key metrics to analyse Natco Pharma?

What is the 52 Week High and Low of Natco Pharma?

What is the trend of Natco Pharma share price?